Mint Tower Capital Management B.V.
Position in SLXN — Silexion Therapeutics Corp
CIK 1666606
AMSTERDAM, P7
Position in SLXN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$0
+$0 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mint Tower Capital Management B.V. holds $2,612,514 across 9 Biotechnology names. SLXN ranks #9 (0.0% of the industry book) .
No Holdings History
No holdings records found for this institution in SLXN.